Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
As the average age of individuals undergoing stem cell transplant continues to increase, challenges associated with balancing the side effects of cancer treatments while also managing other medical conditions develop. Studies have shown these individuals develop more treatment related side effects and take longer to leave the hospital due to complications. The purpose of this study is to develop a multiple provider clinic that will help identify any additional needs in the more complicated and generally older transplant patient population. If needed, this clinic will recommend interventions or referrals to the appropriate specialties to the participant and the transplant physician for the participant before your transplant procedure. Examples of potential areas of improvement include a course of physical therapy, nutritional supplements, or modifications of medications, among others with the goal to make your transplant safer and to decrease length of time in the hospital.
This is a supportive interventional study to assess frailty in at risk geriatric cancer patients undergoing stem cell transplant and to determine if specific interventions are feasible and will improve overall outcomes.
A total of 20 participants will be enrolled in this study with the first 10 participants limited to myeloma or lymphoma patients who meet eligibility criteria and are candidates for autologous transplantation. The second 10 participants enrolled will be either allogeneic or autologous stem cell transplant candidates who meet eligibility criteria.
The objectives of this study are as follows:
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Transplant Wellness Clinic | Experimental |
Recommendations made and given to the participant and sent to the referring MD. Participant receives post clinic phone call before transplant. Referring MD receives questionnaires. Data collected depending on if participant moved forward with transplant |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| physical therapy consult | Other | Physical therapy consult to assess physical functioning on a separate office visit prior to attending the Transplant Wellness Clinic. Full evaluation that incorporates several tools to measure the risk of falling and to assess mobility and strength |
| Measure | Description | Time Frame |
|---|---|---|
| Time to complete geriatric assessment clinic | Time to complete geriatric assessment clinic will be collected. Feasibility will be defined if 7 or more of the first 10 patients are able to complete the geriatric assessment clinic in under 90 minutes. | at time of assessment (an average of 90 minutes) |
| Patient satisfaction as determined by "patient follow-up quesitonnaire" | Analysis of patient and physician questionnaires will be tabulated and results reported in a descriptive fashion | at time of assessment (less than 1 hour) |
| Physician satisfaction as determined by "physician questionnaire" | Analysis of patient and physician questionnaires will be tabulated and results reported in a descriptive fashion | at time of assessment (less than 1 hour) |
| Length of transplant stay in days | Length of transplant stay will be collected for all participants and compared to historical controls of similar age | Assessed up to 6 months after transplant |
| Readmission rates | Readmission rates in the first 100 days post-transplant will be collected and compared to historical controls using Chi-square test | Up to 100 days after transplant |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
- Those who are not felt to be candidates for autologous or allogeneic stem cell transplantation
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Linda M Baer, APRN | University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center | Principal Investigator |
| Brenda H Cooper, MD | University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center | Cleveland | Ohio | 44106 | United States |
Trial does not meet criteria for IPD sharing
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Cognitive Assessment | Other | Montreal cognitive assessment (MoCA) and the Blessed Orientation-Memory-Concentration Test (BOMC) |
|
| Cancer Aging Research Group (CARG) assessment | Other | CARG assessment - utilized to capture information about a participant's medical history as well as functional, cognitive, and psychosocial status |
|
| Medication Review | Other | Medication Review via Beers Assessment |
|
| Nutrition assessment | Other | Nutrition assessment Via Mini Nutrition Assessment (MNA) |
|
| Laboratory studies | Other | Laboratory studies including urine toxicology screen, C-reactive protein, albumin, pre-albumin, vitamin D |
|
| Patient satisfaction questionnaire | Other | Patient satisfaction questionnaire |
|
| Physician Questionnaire | Other | Physician Questionnaire: Questionnaire to learn about physician satisfaction with information received from reports and participant questionnaires. |
|
| Patient follow-up questionnaire | Other | Patient follow-up questionnaire: Questionnaire to learn more about participant opinions concerning the clinic and the quality of care received during visits with specialists |
|
| ID | Term |
|---|---|
| D054219 | Neoplasms, Plasma Cell |
| D008223 | Lymphoma |
| ID | Term |
|---|---|
| D009370 | Neoplasms by Histologic Type |
| D009369 | Neoplasms |
| D008232 | Lymphoproliferative Disorders |
| D008206 | Lymphatic Diseases |
| D006425 | Hemic and Lymphatic Diseases |
| D007160 | Immunoproliferative Disorders |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000073216 | Mental Status and Dementia Tests |
| D012149 | Restraint, Physical |
| D000090143 | Medication Review |
| D015596 | Nutrition Assessment |
| ID | Term |
|---|---|
| D009483 | Neuropsychological Tests |
| D011581 | Psychological Tests |
| D004191 | Behavioral Disciplines and Activities |
| D032763 | Behavior Control |
| D013812 | Therapeutics |
| D007103 | Immobilization |
| D008919 | Investigative Techniques |
| D008509 | Medication Systems |
| D009934 | Organization and Administration |
| D006298 | Health Services Administration |
| D010346 | Patient Care Management |
| D003625 | Data Collection |
| D004812 | Epidemiologic Methods |
| D017531 | Health Care Evaluation Mechanisms |
| D011787 | Quality of Health Care |
| D017530 | Health Care Quality, Access, and Evaluation |
| D015991 | Epidemiologic Measurements |
| D011634 | Public Health |
| D004778 | Environment and Public Health |
Not provided
Not provided